1. Home
  2. KIO vs NPCE Comparison

KIO vs NPCE Comparison

Compare KIO & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KKR Income Opportunities Fund

KIO

KKR Income Opportunities Fund

HOLD

Current Price

$11.12

Market Cap

470.1M

Sector

Finance

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$15.61

Market Cap

432.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KIO
NPCE
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
470.1M
432.3M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
KIO
NPCE
Price
$11.12
$15.61
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$18.33
AVG Volume (30 Days)
244.5K
166.5K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.03
EPS
N/A
N/A
Revenue
N/A
$99,986,000.00
Revenue This Year
N/A
$0.90
Revenue Next Year
N/A
$24.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.13
52 Week Low
$10.65
$7.56
52 Week High
$12.83
$18.97

Technical Indicators

Market Signals
Indicator
KIO
NPCE
Relative Strength Index (RSI) 51.56 63.50
Support Level $10.66 $15.25
Resistance Level $11.24 $15.71
Average True Range (ATR) 0.17 0.66
MACD 0.05 0.22
Stochastic Oscillator 73.73 94.37

Price Performance

Historical Comparison
KIO
NPCE

About KIO KKR Income Opportunities Fund

KKR Income Opportunities Fund operates as a closed-end registered management investment company. The Fund's main objective is to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in a portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: